B2M and hematologic disorder: The serum level of B2M has been established as a prognostic marker in hematologic disorders, solid organ neoplasms, and rheumatic autoimmune diseases (Sjogren’s syndrome, systemic lupus erythematosus, rheumatoid arthritis).